医疗器械巨头波士顿科学（Boston Scientific）周三盘中大涨5.01%，股价创下新高。这一涨势主要受到公司第三季度财报超出市场预期以及上调全年业绩指引的推动。
根据公司公布的财报，波士顿科学第三季度销售额同比增长20%至50.7亿美元，超出分析师预期的49.7亿美元。其中，心血管部门的销售额同比增长22%至33.4亿美元，高于预期的32.7亿美元。调整后每股收益达到75美分，同样超过分析师预期的71美分。
更令投资者振奋的是，波士顿科学上调了2025年全年业绩指引。公司将调整后每股收益预期从此前的2.95至2.99美元上调至3.02至3.04美元。此外，公司预计第四季度净销售额环比增长将在11%至13%之间，展现出强劲的增长势头。这一系列利好消息激发了投资者的信心，推动股价大幅上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.